drugset / Trial / NCT00085371

Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas

NCT00085371

Phase 2 Completed 116 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

This phase II trial is studying how well triapine works as first-line or second-line therapy in treating patients with locally advanced or metastatic adenocarcinoma (cancer) of the pancreas. Drugs used in chemotherapy, such as triapine, work in different ways to stop tumor cells from dividing so they stop growing or die.

Timeline

Start
2004-07
Primary completion
2006-07
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Triapine Small molecule Intravenous